These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 22858003)

  • 21. [Specific inhibition of HER-2 expression in ovarian carcinoma cells by siRNA targeting HER-2].
    Lu YM; Zhang SL; Meng LR; Zhao YY
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):619-23. PubMed ID: 16681908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers.
    Ofek P; Fischer W; Calderón M; Haag R; Satchi-Fainaro R
    FASEB J; 2010 Sep; 24(9):3122-34. PubMed ID: 20385622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: the role of genes associated with the NF-kappaB pathway.
    Shaikh IA; Brown I; Schofield AC; Wahle KW; Heys SD
    Prostate; 2008 Nov; 68(15):1635-46. PubMed ID: 18668525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Downregulation of p57kip² promotes cell invasion via LIMK/cofilin pathway in human nasopharyngeal carcinoma cells.
    Chow SE; Wang JS; Lin MR; Lee CL
    J Cell Biochem; 2011 Nov; 112(11):3459-68. PubMed ID: 21769918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticancer effect of docetaxel induces apoptosis of prostate cancer via the cofilin-1 and paxillin signaling pathway.
    Xiao P; Ma T; Zhou C; Xu Y; Liu Y; Zhang H
    Mol Med Rep; 2016 May; 13(5):4079-84. PubMed ID: 27035282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apoptotic activity and mechanism of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic-acid and related synthetic triterpenoids in prostate cancer.
    Hyer ML; Shi R; Krajewska M; Meyer C; Lebedeva IV; Fisher PB; Reed JC
    Cancer Res; 2008 Apr; 68(8):2927-33. PubMed ID: 18413762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. siRNA-mediated silencing of Notch-1 enhances docetaxel induced mitotic arrest and apoptosis in prostate cancer cells.
    Ye QF; Zhang YC; Peng XQ; Long Z; Ming YZ; He LY
    Asian Pac J Cancer Prev; 2012; 13(6):2485-9. PubMed ID: 22938409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RPN2 gene confers docetaxel resistance in breast cancer.
    Honma K; Iwao-Koizumi K; Takeshita F; Yamamoto Y; Yoshida T; Nishio K; Nagahara S; Kato K; Ochiya T
    Nat Med; 2008 Sep; 14(9):939-48. PubMed ID: 18724378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
    Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
    Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer.
    Zha S; Ferdinandusse S; Denis S; Wanders RJ; Ewing CM; Luo J; De Marzo AM; Isaacs WB
    Cancer Res; 2003 Nov; 63(21):7365-76. PubMed ID: 14612535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downmodulation of Bcl-2 sensitizes metastatic LNCaP-LN3 cells to undergo apoptosis via the intrinsic pathway.
    Song R; Harris LD; Pettaway CA
    Prostate; 2010 May; 70(6):571-83. PubMed ID: 19938012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pretreatment of docetaxel enhances TRAIL-mediated apoptosis in prostate cancer cells.
    Yoo J; Park SS; Lee YJ
    J Cell Biochem; 2008 Aug; 104(5):1636-46. PubMed ID: 18404675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3,3'-Diindolylmethane enhances taxotere-induced apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation.
    Rahman KM; Banerjee S; Ali S; Ahmad A; Wang Z; Kong D; Sakr WA
    Cancer Res; 2009 May; 69(10):4468-75. PubMed ID: 19435906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low dose combinations of 2-methoxyestradiol and docetaxel block prostate cancer cells in mitosis and increase apoptosis.
    Reiner T; de las Pozas A; Gomez LA; Perez-Stable C
    Cancer Lett; 2009 Apr; 276(1):21-31. PubMed ID: 19046802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
    Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
    Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overcoming drug resistance of MCF-7/ADR cells by altering intracellular distribution of doxorubicin via MVP knockdown with a novel siRNA polyamidoamine-hyaluronic acid complex.
    Han M; Lv Q; Tang XJ; Hu YL; Xu DH; Li FZ; Liang WQ; Gao JQ
    J Control Release; 2012 Oct; 163(2):136-44. PubMed ID: 22940126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tailoring nanostructured solid-lipid carriers for time-controlled intracellular siRNA kinetics to sustain RNAi-mediated chemosensitization.
    Xue HY; Wong HL
    Biomaterials; 2011 Apr; 32(10):2662-72. PubMed ID: 21236485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The inhibition of human bladder cancer growth by calcium carbonate/CaIP6 nanocomposite particles delivering AIB1 siRNA.
    Wei J; Cheang T; Tang B; Xia H; Xing Z; Chen Z; Fang Y; Chen W; Xu A; Wang S; Luo J
    Biomaterials; 2013 Jan; 34(4):1246-54. PubMed ID: 23127333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of candidate biomarkers of therapeutic response to docetaxel by proteomic profiling.
    Zhao L; Lee BY; Brown DA; Molloy MP; Marx GM; Pavlakis N; Boyer MJ; Stockler MR; Kaplan W; Breit SN; Sutherland RL; Henshall SM; Horvath LG
    Cancer Res; 2009 Oct; 69(19):7696-703. PubMed ID: 19773444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.